Another study found that CD69 could serve as a prognostic marker for SKCM, influencing immune response through interactions with genes like PTPRC and IL7R, and impacting tumor progression by regulating the tumor immune microenvironment (55). The gene discussed is CD69; the disease is neoplasm.